PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Petri, Michelle
TI  - Randomized Controlled Trials of Epratuzumab Reveal Clinically Meaningful Improvements in Patients with Moderate/Severe SLE Flares
DP  - 2008 Sep 01
TA  - MD Conference Express
PG  - 16--17
VI  - 8
IP  - 5
4099  - http://mdc.sagepub.com/content/8/5/16.short
4100  - http://mdc.sagepub.com/content/8/5/16.full
AB  - This article discusses results of 2 48-week, randomized, double-blind, placebo-controlled clinical trials that evaluated the humanized anti-CD22 monoclonal antibody epratuzumab for the treatment of patients with severe BILAG A or moderate BILAG B (in =2 organ systems) systemic lupus erythematosus flares.